May 11-14, 2026
Sheraton San Diego Resort | San Diego , CA
Connect With Us at AAPS National Biotechnology Conference (NBC) 2026
BioData Solutions is excited to participate in one of the leading events for biopharmaceutical development, bioanalysis, and translational science, bringing together experts across biologics, cell and gene therapy (CGT), pharmacokinetics (PK), and immunogenicity.
Featured Presentation
AI-Driven Biomarker and Diagnostic Testing
Stephanie Pasas-Farmer, PhD
May 12 | 10:30 AM – 11:00 AM PT
This session will explore how artificial intelligence is transforming biomarker and diagnostic testing through improved data integration, analytical consistency, and translational decision-making. Attendees will gain insight into scalable, reproducible, and regulatory-ready approaches supporting biologics and advanced therapeutic programs.
Additional Sessions
Laboratory AI Literacy: Accelerating Research Through Human-AI Training Parallelization
Moderator: Stephanie Pasas-Farmer, PhD
Thursday, May 14 | 9:30 AM – 10:30 AM PT
A discussion on building AI literacy within laboratory environments to support effective collaboration between scientists and AI-enabled technologies.
Finding the Right Patients: Diagnostic-Driven Commercialization for Emerging Therapies
Moderator: Joleen T. White, PhD
Thursday, May 14 | 11:00 AM – 12:00 PM PT
This keynote session will examine how diagnostic strategies are shaping patient identification and commercialization pathways for emerging therapies.
Meet the Team
- Joleen T. White, PhD — Expert in immunogenicity, biomarkers, and regulatory strategy
- Stephanie Pasas-Farmer, PhD — Leader in CGT, immunogenicity, and translational bioanalysis
Connect with the BioData Solutions team at NBC 2026 to discuss biomarker strategy, bioanalytical development, AI-enabled laboratory innovation, and regulatory readiness for advanced therapeutic programs.